Access cutting-edge dravet syndrome treatment through this clinical trial at a research site in Miami. Study-provided care at no cost to qualified participants.
Access dravet syndrome specialists in Miami at no cost
This study follows strict safety protocols and ethical guidelines
All study-related dravet syndrome treatment provided free
This (DEEp SEA Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DS. The study consists of 3 main phases: Screening, Titration period, and Maintenance period, followed by a Taper period and Follow-Up. Participants will be randomized to LP352 or placebo. The total duration of the study will be approximately 24 months.
Sponsor: Longboard Pharmaceuticals
Check if you qualify for this dravet syndrome clinical trial in Miami, FL
If you're searching for dravet syndrome treatment options in Miami, FL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Miami research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dravet syndrome specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.